Press Releases
Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity
Amarantus Outlines MANF Research Collaboration Strategy
Amarantus Strengthens Management Team With Key Additions in Business Development and Regulatory Affairs
CEO Gerald Commissiong of Amarantus to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW 1190AM
Amarantus Bioscience Holdings Announces $3M Solicitation of Previously Issued Warrants
Amarantus to Present at 16th Annual BIO CEO & Investor Conference
Amarantus Announces Positive Phase 2a Data for Eltoprazine in Adult ADHD
Amarantus Establishes LymPro Research Collaboration With Boston University School of Medicine